首页> 美国卫生研究院文献>Case Reports in Nephrology and Dialysis >A Case of Recurrent Proliferative Glomerulonephritis with Monoclonal IgG Deposits after Kidney Transplant Treated with Plasmapheresis
【2h】

A Case of Recurrent Proliferative Glomerulonephritis with Monoclonal IgG Deposits after Kidney Transplant Treated with Plasmapheresis

机译:血浆置换治疗肾脏移植术后复发性增殖性肾小球肾炎合并单克隆IgG沉积的病例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) is a rare and recently identified disease with a poor prognosis irrespective of the treatment. Recently, the possibility of recurrent or de novo PGNMID after kidney transplantation has been reported, which is associated with a better prognosis compared to PGNMID on native kidneys. Nevertheless, at present, due to the very few cases of recurrent PGNMID diagnosed, there is no proven effective treatment. Here, we report a case of recurrent PGNMID successfully treated with plasmapheresis, steroids and mycophenolate mofetil. Our report suggests that plasmapheresis might be a valid therapeutic option to treat recurrent PGNMID.
机译:具有单克隆IgG沉积物(PGNMID)的增生性肾小球肾炎是一种罕见的,最近发现的疾病,与治疗无关,其预后很差。最近,已经报道了肾脏移植后复发或重新发生PGNMID的可能性,与天然肾脏上的PGNMID相比,它与更好的预后相关。尽管如此,目前,由于确诊的复发性PGNMID病例极少,因此没有有效的治疗方法。在这里,我们报告一例成功用血浆置换术,类固醇和霉酚酸酯治疗的复发性PGNMID。我们的报告表明血浆置换术可能是治疗复发性PGNMID的有效治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号